| 28.88 -0.657 (-2.22%) | 05-29 15:57 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 35.77 |
1-year : | 41.78 |
| Resists | First : | 30.62 |
Second : | 35.77 |
| Pivot price | 27.56 |
|||
| Supports | First : | 27.48 |
Second : | 25.54 |
| MAs | MA(5) : | 27.67 |
MA(20) : | 28.05 |
| MA(100) : | 25.62 |
MA(250) : | 24.83 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 59.3 |
D(3) : | 41.9 |
| RSI | RSI(14): 55.9 |
|||
| 52-week | High : | 43.93 | Low : | 13.96 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CNBS ] has closed below upper band by 22.8%. Bollinger Bands are 7.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 29.79 - 29.94 | 29.94 - 30.05 |
| Low: | 28.48 - 28.67 | 28.67 - 28.84 |
| Close: | 28.6 - 28.9 | 28.9 - 29.14 |
CNBS is an actively managed ETF that provides diversified U.S. exposure across the cannabis ecosystem including cannabis: plants, support, and ancillary businesses. CNBS seeks to provide capital appreciation.
Fri, 08 May 2026
Best Cannabis ETFs to Buy in 2026 and How to Invest - The Motley Fool
Thu, 30 Apr 2026
Cannabis ETFs: Regulatory Momentum Returns Focus - ETF Trends
Mon, 27 Apr 2026
Amplify Seymour Cannabis ETF (CNBS) News - The Daily Upside
Thu, 23 Apr 2026
The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading - 24/7 Wall St.
Fri, 02 Jan 2026
After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS - 24/7 Wall St.
Thu, 18 Dec 2025
CNBS: New Buy Rating On Cannabis ETF, Stoked By Positive Regulatory Trend (NYSEARCA:CNBS) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |